Lactobacillus rhamnosus GG Outcompetes Enterococcus faecium via Mucus-Binding Pili: Evidence for a Novel and Heterospecific Probiotic Mechanism

Applied and Environmental Microbiology

Volumn 82, Issue 19, 2016, Pages 5756-5762

  Tytgat, Hanne L P ^a   Douillard, François P ^b   Reunanen, Justus ^b   Rasinkangas, Pia ^b   Hendrickx, Antoni P A ^c   Laine, Pia K ^d   Paulin, Lars ^d   Satokari, Reetta ^b,e   de Vos, Willem M ^a,b,e  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY OF HELSINKI   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BACILLI; PATHOGENS;

ANTIBIOTIC RESISTANCE; ENTEROCOCCUS FAECIUM; FUNCTIONAL SIMILARITY; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS RHAMNOSUS STRAIN; MOLECULAR MECHANISM; SEQUENCE SIMILARITY; VANCOMYCIN-RESISTANT ENTEROCOCCI;

BODY FLUIDS;

ANTIBIOTIC RESISTANCE; ANTIBODY; BACTERIUM; BIOTECHNOLOGY; GENOME; HOST-PATHOGEN INTERACTION; INFECTIVITY; MUCUS; PATHOGEN; PROTEIN;

ENTEROCOCCUS FAECIUM; LACTOBACILLUS RHAMNOSUS;

PROBIOTIC AGENT;

ENTEROCOCCUS FAECIUM; FIMBRIA; HUMAN; LACTOBACILLUS RHAMNOSUS; METABOLISM; MICROBIOLOGY; MUCUS; ORGANISMAL INTERACTION; PHYSIOLOGY;

ENTEROCOCCUS FAECIUM; FIMBRIAE, BACTERIAL; HUMANS; LACTOBACILLUS RHAMNOSUS; MICROBIAL INTERACTIONS; MUCUS; PROBIOTICS;

EID: 84987864202     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.01243-16     Document Type: Article

References (41)

1. Sghir A, Gramet G, Suau A, Rochet V, Pochart P, Dore J. 2000. Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization. Appl Environ Microbiol 66:2263-2266. http://dx.doi.org/10.1128/AEM.66.5.2263-2266.2000.
2. Franz CM, Huch M, Abriouel H, Holzapfel W, Galvez A. 2011. Enterococci as probiotics and their implications in food safety. Int J Food Microbiol 151:125-140. http://dx.doi.org/10.1016/j.ijfoodmicro.2011.08.014.
3. Uttley AH, Collins CH, Naidoo J, George RC. 1988. Vancomycinresistant enterococci. Lancet i:57-58.
4. O'Driscoll T, Crank CW. 2015. Vancomycin-resistant enterococcal in-fections: epidemiology, clinical manifestations, and optimal management. Infect Drug Resist 8:217-230. http://dx.doi.org/10.2147/IDR.S54125.
5. Carmeli Y, Eliopoulos G, Mozaffari E, Samore M. 2002. Health and economic outcomes of vancomycin-resistant enterococci. Arch Intern Med 162:2223-2228. http://dx.doi.org/10.1001/archinte.162.19.2223.
6. Bonten MJ, Willems R, Weinstein RA. 2001. Vancomycin-resistant enterococci: why are they here, and where do they come from? Lancet Infect Dis 1:314-325. http://dx.doi.org/10.1016/S1473-3099(01)00145-1.
7. Cattoir V, Leclercq R. 2013. Twenty-five years of shared life with vancomycin-resistant enterococci: is it time to divorce? J Antimicrob Chemother 68:731-742. http://dx.doi.org/10.1093/jac/dks469.
8. Murray BE. 2000. Vancomycin-resistant enterococcal infections. N Engl J Med 342:710-721. http://dx.doi.org/10.1056/NEJM200003093421007.
9. Mutters NT, Mersch-Sundermann V, Mutters R, Brandt C, Schneider-Brachert W, Frank U. 2013. Control of the spread of vancomycinresistant enterococci in hospitals: epidemiology and clinical relevance. Dtsch Arztebl Int 110:725-731. http://dx.doi.org/10.3238/arztebl.2013.0725.
10. Hendrickx AP, van Schaik W, Willems RJ. 2013. The cell wall architecture of Enterococcus faecium: from resistance to pathogenesis. Future Microbiol 8:993-1010. http://dx.doi.org/10.2217/fmb.13.66.
11. Zirakzadeh A, Patel R. 2005. Epidemiology and mechanisms of glycopeptide resistance in enterococci. Curr Opin Infect Dis 18:507-512. http://dx.doi.org/10.1097/01.qco.0000186849.54040.2a.
12. World Health Organization. 2015. 19th WHO model list of essential medicines. World Health Organization, Geneva, Switzerland.
13. Cheng VC, Chen JH, Tai JW, Wong SC, Poon RW, Hung IF, To KK, Chan JF, Ho PL, Lo CM, Yuen KY. 2014. Decolonization of gastrointestinal carriage of vancomycin-resistant Enterococcus faecium: case series and review of literature. BMCInfect Dis 14:514. http://dx.doi.org/10.1186/1471-2334-14-514.
14. Kim AS. 2011. Using the good to beat out the bad: probiotics for eliminating vancomycin-resistant enterococci colonization. J Clin Gastroenterol 45:844-845. http://dx.doi.org/10.1097/MCG.0b013e31823336cd.
15. Doron S, Hibberd PL, Goldin B, Thorpe C, McDermott L, Snydman DR. 2015. Effect of Lactobacillus rhamnosus GG administration on vancomycin-resistant Enterococcus colonization in adults with comorbidities. Antimicrob Agents Chemother 59:4593-4599. http://dx.doi.org/10.1128/AAC.00300-15.
16. Manley KJ, Fraenkel MB, Mayall BC, Power DA. 2007. Probiotic treatment of vancomycin-resistant enterococci: a randomised controlled trial. Med J Aust 186:454-457.
17. Szachta P, Ignys I, Cichy W. 2011. An evaluation of the ability of the probiotic strain Lactobacillus rhamnosus GG to eliminate the gastrointestinal carrier state of vancomycin-resistant enterococci in colonized children. J Clin Gastroenterol 45:872-877. http://dx.doi.org/10.1097/MCG.0b013e318227439f.
18. Sun Z, Harris HM, McCann A, Guo C, Argimon S, Zhang W, Yang X, Jeffery IB, Cooney JC, Kagawa TF, Liu W, Song Y, Salvetti E, Wrobel A, Rasinkangas P, Parkhill J, Rea MC, O'Sullivan O, Ritari J, Douillard FP, Paul Ross R, Yang R, Briner AE, Felis GE, de Vos WM, Barrangou R, Klaenhammer TR, Caufield PW, Cui Y, Zhang H, O'Toole PW. 2015. Expanding the biotechnology potential of lactobacilli through comparative genomics of 213 strains and associated genera. Nat Commun 6:8322. http://dx.doi.org/10.1038/ncomms9322.
19. Danne C, Dramsi S. 2012. Pili of gram-positive bacteria: roles in host colonization. Res Microbiol 163:645-658. http://dx.doi.org/10.1016/j.resmic.2012.10.012.
20. Douillard FP, de Vos WM. 2014. Functional genomics of lactic acid bacteria: from food to health. Microb Cell Fact 13(Suppl):S8. http://dx.doi.org/10.1186/1475-2859-13-S1-S8.
21. Kankainen M, Paulin L, Tynkkynen S, von Ossowski I, Reunanen J, Partanen P, Satokari R, Vesterlund S, Hendrickx AP, Lebeer S, De Keersmaecker SC, Vanderleyden J, Hamalainen T, Laukkanen S, Salovuori N, Ritari J, Alatalo E, Korpela R, Mattila-Sandholm T, Lassig A, Hatakka K, Kinnunen KT, Karjalainen H, Saxelin M, Laakso K, Surakka A, Palva A, Salusjarvi T, Auvinen P, de Vos WM. 2009. Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human-mucus binding protein. Proc Natl Acad Sci U S A 106:17193-17198. http://dx.doi.org/10.1073/pnas.0908876106.
22. Lebeer S, Claes I, Tytgat HL, Verhoeven TL, Marien E, von Ossowski I, Reunanen J, Palva A, de Vos WM, De Keersmaecker SC, Vanderleyden J. 2012. Functional analysis of Lactobacillus rhamnosus GG pili in relation to adhesion and immunomodulatory interactions with intestinal epithelial cells. Appl Environ Microbiol 78:185-193. http://dx.doi.org/10.1128/AEM.06192-11.
23. Reunanen J, von Ossowski I, Hendrickx AP, Palva A, de Vos WM. 2012. Characterization of the SpaCBA pilus fibers in the probiotic Lactobacillus rhamnosus GG. Appl Environ Microbiol 78:2337-2344. http://dx.doi.org/10.1128/AEM.07047-11.
24. von Ossowski I, Reunanen J, Satokari R, Vesterlund S, Kankainen M, Huhtinen H, Tynkkynen S, Salminen S, de Vos WM, Palva A. 2010. Mucosal adhesion properties of the probiotic Lactobacillus rhamnosus GG SpaCBA and SpaFED pilin subunits. Appl Environ Microbiol 76:2049-2057. http://dx.doi.org/10.1128/AEM.01958-09.
25. Hendrickx AP, Bonten MJ, van Luit-Asbroek M, Schapendonk CM, Kragten AH, Willems RJ. 2008. Expression of two distinct types of pili by a hospital-acquired Enterococcus faecium isolate. Microbiology 154:3212-3223. http://dx.doi.org/10.1099/mic.0.2008/020891-0.
26. Hendrickx AP, van Wamel WJ, Posthuma G, Bonten MJ, Willems RJ. 2007. Five genes encoding surface-exposed LPXTG proteins are enriched in hospital-adapted Enterococcus faecium clonal complex 17 isolates. J Bacteriol 189:8321-8332. http://dx.doi.org/10.1128/JB.00664-07.
27. Aziz RK, Bartels D, Best AA, DeJongh M, Disz T, Edwards RA, Formsma K, Gerdes S, Glass EM, Kubal M, Meyer F, Olsen GJ, Olson R, Osterman AL, Overbeek RA, McNeil LK, Paarmann D, Paczian T, Parrello B, Pusch GD, Reich C, Stevens R, Vassieva O, Vonstein V, Wilke A, Zagnitko O. 2008. The RAST server: rapid annotations using subsystems technology. BMC Genomics 9:75. http://dx.doi.org/10.1186/1471-2164-9-75.
28. Tytgat HL, van Teijlingen NH, Sullan RM, Douillard FP, Rasinkangas P, Messing M, Reunanen J, Satokari R, Vanderleyden J, Dufrene YF, Geijtenbeek TB, de Vos WM, Lebeer S. 2016. Probiotic gut microbiota isolate interacts with dendritic cells via glycosylated heterotrimeric pili. PLoS One 11:e0151824. http://dx.doi.org/10.1371/journal.pone.0151824.
29. Espino E, Koskenniemi K, Mato-Rodriguez L, Nyman TA, Reunanen J, Koponen J, Ohman T, Siljamaki P, Alatossava T, Varmanen P, Savijoki K. 2015. Uncovering surface-exposed antigens of Lactobacillus rhamnosus by cell shaving proteomics and two-dimensional immunoblotting. J Proteome Res 14:1010-1024. http://dx.doi.org/10.1021/pr501041a.
30. Vesterlund S, Paltta J, Karp M, Ouwehand AC. 2005. Measurement of bacterial adhesion-in vitro evaluation of different methods. J Microbiol Methods 60:225-233. http://dx.doi.org/10.1016/j.mimet.2004.09.013.
31. Rasinkangas P, Reunanen J, Douillard FP, Ritari J, Uotinen V, Palva A, de Vos WM. 2014. Genomic characterization of non-mucus-adherent derivatives of Lactobacillus rhamnosus GG reveals genes affecting pilus biogenesis. Appl Environ Microbiol 80:7001-7009. http://dx.doi.org/10.1128/AEM.02006-14.
32. Vargas Garcia CE, Petrova M, Claes IJ, De Boeck I, Verhoeven TL, Dilissen E, von Ossowski I, Palva A, Bullens DM, Vanderleyden J, Lebeer S. 2015. Piliation of Lactobacillus rhamnosus GG promotes adhesion, phagocytosis, and cytokine modulation in macrophages. Appl Environ Microbiol 81:2050-2062. http://dx.doi.org/10.1128/AEM.03949-14.
33. Proft T, Baker EN. 2009. Pili in Gram-negative and Gram-positive bacteria- structure, assembly and their role in disease. Cell Mol Life Sci 66: 613-635. http://dx.doi.org/10.1007/s00018-008-8477-4.
34. Telford JL, Barocchi MA, Margarit I, Rappuoli R, Grandi G. 2006. Pili in Gram-positive pathogens. Nat Rev Microbiol 4:509-519. http://dx.doi.org/10.1038/nrmicro1443.
35. Qin X, Galloway-Pena JR, Sillanpaa J, Roh JH, Nallapareddy SR, Chowdhury S, Bourgogne A, Choudhury T, Muzny DM, Buhay CJ, Ding Y, Dugan-Rocha S, Liu W, Kovar C, Sodergren E, Highlander S, Petrosino JF, Worley KC, Gibbs RA, Weinstock GM, Murray BE. 2012. Complete genome sequence of Enterococcus faecium strain TX16 and comparative genomic analysis of Enterococcus faecium genomes. BMC Microbiol 12:135. http://dx.doi.org/10.1186/1471-2180-12-135.
36. Tripathi P, Beaussart A, Alsteens D, Dupres V, Claes I, von Ossowski I, de Vos WM, Palva A, Lebeer S, Vanderleyden J, Dufrene YF. 2013. Adhesion and nanomechanics of pili from the probiotic Lactobacillus rhamnosus GG. ACS Nano 7:3685-3697. http://dx.doi.org/10.1021/nn400705u.
37. Kim DS, Singh KV, Nallapareddy SR, Qin X, Panesso D, Arias CA, Murray BE. 2010. The fms21 (pilA)-fms20 locus encoding one of four distinct pili of Enterococcus faecium is harboured on a large transferable plasmid associated with gut colonization and virulence. J Med Microbiol 59:505-507. http://dx.doi.org/10.1099/jmm.0.016238-0.
38. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM, Bertalan M, Borruel N, Casellas F, Fernandez L, Gautier L, Hansen T, Hattori M, Hayashi T, Kleerebezem M, Kurokawa K, Leclerc M, Levenez F, Manichanh C, Nielsen HB, Nielsen T, Pons N, Poulain J, Qin J, Sicheritz-Ponten T, Tims S, Torrents D, Ugarte E, Zoetendal EG, Wang J, Guarner F, Pedersen O, de Vos WM, Brunak S, Dore J, Antolin M, Artiguenave F, Blottiere HM, Almeida M, Brechot C, Cara C, Chervaux C, Cultrone A, Delorme C, Denariaz G, Dervyn R, et al. 2011. Enterotypes of the human gut microbiome. Nature 473:174-180. http://dx.doi.org/10.1038/nature09944.
39. Krogfelt KA. 1991. Bacterial adhesion: genetics, biogenesis, and role in pathogenesis of fimbrial adhesins of Escherichia coli. Rev Infect Dis 13: 721-735. http://dx.doi.org/10.1093/clinids/13.4.721.
40. Palmer KL, Gilmore MS. 2010. Multidrug-resistant enterococci lack CRISPR-cas. mBio 1:e00227-10. http://dx.doi.org/10.1128/mBio.00227-10.
41. Grissa I, Vergnaud G, Pourcel C. 2007. The CRISPRdb database and tools to display CRISPRs and to generate dictionaries of spacers and repeats. BMC Bioinformatics 8:172. http://dx.doi.org/10.1186/1471-2105-8-172.